Skip to main navigation Skip to search Skip to main content

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

  • W. Cozen
  • , M. N. Timofeeva
  • , D. Li
  • , A. Diepstra
  • , D. Hazelett
  • , M. Delahaye-Sourdeix
  • , C. K. Edlund
  • , L. Franke
  • , K. Rostgaard
  • , D. J. Van Den Berg
  • , V. K. Cortessis
  • , K. E. Smedby
  • , S. L. Glaser
  • , H. J. Westra
  • , L. L. Robison
  • , T. M. Mack
  • , H. Ghesquieres
  • , A. E. Hwang
  • , A. Nieters
  • , S. De Sanjose
  • T. Lightfoot, N. Becker, M. Maynadie, L. Foretova, E. Roman, Y. Benavente, K. A. Rand, B. N. Nathwani, B. Glimelius, A. Staines, P. Boffetta, B. K. Link, L. Kiemeney, S. M. Ansell, S. Bhatia, L. C. Strong, P. Galan, L. Vatten, T. M. Habermann, E. J. Duell, A. Lake, R. N. Veenstra, L. Visser, Y. Liu, K. Y. Urayama, D. Montgomery, V. Gaborieau, L. M. Weiss, G. Byrnes, M. Lathrop, P. Cocco, T. Best, A. D. Skol, H. O. Adami, M. Melbye, J. R. Cerhan, A. Gallagher, G. M. Taylor, S. L. Slager, P. Brennan, G. A. Coetzee, D. V. Conti, K. Onel, R. F. Jarrett, H. Hjalgrim, A. Van Den Berg, J. D. McKay
  • University of Southern California
  • International Agency for Research on Cancer
  • University of Edinburgh
  • Cedars-Sinai Medical Center
  • University of Groningen
  • Statens Serum Institut
  • Karolinska Institutet
  • Cancer Prevention Institute of California
  • St. Jude Children Research Hospital
  • Universite Claude Bernard Lyon 1
  • University of Freiburg
  • Institute Catala Oncologia
  • University of York
  • German Cancer Research Center
  • Université de Bourgogne
  • Masaryk Memorial Cancer Institute
  • City of Hope National Med Center
  • Uppsala University
  • Dublin City University
  • University of Iowa
  • Radboud University Nijmegen
  • Mayo Clinic Rochester, MN
  • University of Texas MD Anderson Cancer Center
  • Institut national de la santé et de la recherche médicale
  • Norwegian University of Science and Technology
  • MRC-University of Glasgow Centre for Virus Research
  • Institute of Science Tokyo
  • Clarient Pathology Services
  • Genome Quebec
  • University of Cagliari
  • The University of Chicago
  • Harvard University
  • University of Manchester

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Abstract

Recent genome-wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis of three HL GWAS totaling 1,816 cases and 7,877 controls followed by replication in an independent set of 1,281 cases and 3,218 controls to find novel risk loci. We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR)=0.81, 95% confidence interval (95% CI)=0.76-0.86, P combined =3.5 × 10 10), located in intron 2 of TCF3 (also known as E2A), a regulator of B-and T-cell lineage commitment known to be involved in HL pathogenesis. This meta-analysis also notes associations between previously published loci at 2p16, 5q31, 6p31, 8q24 and 10p14 and HL subtypes. We conclude that our data suggest a link between the 19p13.3 locus, including TCF3, and HL risk.

Original languageEnglish
Article number3856
JournalNature Communications
Volume5
DOIs
StatePublished - Jun 12 2014

Fingerprint

Dive into the research topics of 'A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus'. Together they form a unique fingerprint.

Cite this